Skip to main content

Human Calcitonin Administered by the Nasal Route: Bioavailability of Different Formulations and Efficacy in Post-Menopausal Osteoporosis

  • Chapter
  • 148 Accesses

Part of the book series: NATO ASI Series ((NSSA,volume 125))

Abstract

After its discovery by Copp et al. in 1962, calcitonin has been employed in the management of several bone diseases, for instance postmenopausal osteoporosis and Paget’s disease. Treatment of the above disease requires i.m. or s.c. administrations daily or on alternate days for prolonged periods, and this can reduce patient compliance during the course of the disease (Stevenson et al., 1981).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Austin L. A., and Heat H., 1981, Calcitonin., New Engl. Med. J., 304: 269.

    Article  CAS  Google Scholar 

  • Copp D. H., Cameron B. A., Cheney B. A., Davidson A. G. F., and Henze K. G., 1962, Evidence for calcitonin: a new hormone from the parathyroid that lowers blood calcium, Endocrinology, 70: 638.

    Article  PubMed  CAS  Google Scholar 

  • Heerse J. N. M., Marcus R., and Aurbach G. D., 1974, Calcitonin and formation of 3′5′-AMP in bone and kidney., Endocrinology, 94: 241.

    Article  Google Scholar 

  • Pontiroli A. E., Alberetto M., and Pozza O., 1985, Intranasal calcitonin and plasma calcium concentrations in normal subjects., Brit. Med. Journal, 290:1390.

    Article  CAS  Google Scholar 

  • Reginster J. Y., Albert A., and Franchimont P., 1985, Salmon calcitonin nasal spray in Paget’s disease of bone. Calcified Tissue International, 37: 577.

    Article  PubMed  CAS  Google Scholar 

  • Ziegler R., Holz G., Raue F., and Streibl W., 1979, Nasal application of human calcitonin in Paaet’s disease of bone., Mol. Endocrinoi. 1: 293.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pontiroli, A.E. et al. (1986). Human Calcitonin Administered by the Nasal Route: Bioavailability of Different Formulations and Efficacy in Post-Menopausal Osteoporosis. In: Davis, S.S., Illum, L., Tomlinson, E. (eds) Delivery Systems for Peptide Drugs. NATO ASI Series, vol 125. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9960-6_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9960-6_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9962-0

  • Online ISBN: 978-1-4757-9960-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics